1. Home
  2. MYNZ vs FBGL Comparison

MYNZ vs FBGL Comparison

Compare MYNZ & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • FBGL
  • Stock Information
  • Founded
  • MYNZ 2021
  • FBGL 1996
  • Country
  • MYNZ Germany
  • FBGL Singapore
  • Employees
  • MYNZ N/A
  • FBGL N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • FBGL Miscellaneous manufacturing industries
  • Sector
  • MYNZ Health Care
  • FBGL Consumer Discretionary
  • Exchange
  • MYNZ Nasdaq
  • FBGL Nasdaq
  • Market Cap
  • MYNZ 8.0M
  • FBGL 7.8M
  • IPO Year
  • MYNZ 2021
  • FBGL 2025
  • Fundamental
  • Price
  • MYNZ $2.08
  • FBGL $0.66
  • Analyst Decision
  • MYNZ Buy
  • FBGL
  • Analyst Count
  • MYNZ 2
  • FBGL 0
  • Target Price
  • MYNZ $14.00
  • FBGL N/A
  • AVG Volume (30 Days)
  • MYNZ 93.5K
  • FBGL 141.9K
  • Earning Date
  • MYNZ 06-17-2025
  • FBGL 01-01-0001
  • Dividend Yield
  • MYNZ N/A
  • FBGL N/A
  • EPS Growth
  • MYNZ N/A
  • FBGL N/A
  • EPS
  • MYNZ N/A
  • FBGL N/A
  • Revenue
  • MYNZ $893,991.00
  • FBGL $10,146,582.00
  • Revenue This Year
  • MYNZ $26.06
  • FBGL N/A
  • Revenue Next Year
  • MYNZ $4.97
  • FBGL N/A
  • P/E Ratio
  • MYNZ N/A
  • FBGL N/A
  • Revenue Growth
  • MYNZ N/A
  • FBGL N/A
  • 52 Week Low
  • MYNZ $1.92
  • FBGL $0.44
  • 52 Week High
  • MYNZ $34.00
  • FBGL $5.45
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 38.07
  • FBGL N/A
  • Support Level
  • MYNZ $1.93
  • FBGL N/A
  • Resistance Level
  • MYNZ $2.10
  • FBGL N/A
  • Average True Range (ATR)
  • MYNZ 0.16
  • FBGL 0.00
  • MACD
  • MYNZ 0.04
  • FBGL 0.00
  • Stochastic Oscillator
  • MYNZ 30.39
  • FBGL 0.00

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.

Share on Social Networks: